LDS/Medical Tests/Diphtheria Toxoid Antibody, IgG

Diphtheria Toxoid Antibody, IgG

Corynebacterium diphtheriae is a gram-positive, aerobic bacterium that produces diphtheria toxin, the main virulence factor responsible for disease severity. Diphtheria primarily affects the upper respiratory tract but may also involve skin and other organs. Transmission occurs through respiratory droplets or contact with contaminated surfaces. Once inhaled, the organism colonizes the mucosa of the pharynx, tonsils, or larynx. The diphtheria toxin, encoded by a bacteriophage-carried tox gene, binds to heparin-binding epidermal growth factor receptor (HB-EGF) on host cells, enters the cytosol, and irreversibly inactivates elongation factor-2 (EF-2) by ADP-ribosylation, halting protein synthesis and causing cell death.

The Diphtheria Toxoid Antibody (IgG) test measures IgG antibodies produced in response to diphtheria toxoid vaccination. Protective antibody levels are essential for immunity. Individuals with low or undetectable antibody levels may be susceptible to diphtheria and may require booster immunization.

  • Evaluates immune response to diphtheria vaccination
  • Identifies individuals who may require booster immunization
≥0.1 IU/mL: Protective immunity. 0.01–<0.1 IU/mL: Minimal protection; booster dose recommended. <0.01 IU/mL: Non-protective; individual considered susceptible.

Vaccinated: Positive: >=0.01 IU/mL Unvaccinated: Negative: <0.01 IU/mL 

Enzyme-linked immunosorbent assay (ELISA).

Serum, SST tube.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Throat swab culture, Gram stain, Albert’s stain.
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login